Does ADMA Biologics' (ADMA) Rebuttal to Short-Seller Claims Strengthen Its Management Credibility Narrative? [Yahoo! Finance]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Yahoo! Finance
disclosures, channel stuffing, and improper reporting around its ASCENIV immune globulin therapy. The company highlighted distributor and customer data showing record demand for ASCENIV, underscored its premium late-line positioning, and pointed to clean, unqualified auditor opinions as evidence supporting its financial integrity. Now we'll examine how ADMA's firm rejection of channel-stuffing allegations and emphasis on ASCENIV demand affects its investment narrative. The latest GPUs need a type of rare earth metal called Dysprosium and there are only 26 companies in the world exploring or producing it . Find the list for free. ADMA Biologics Investment Narrative Recap To own ADMA, you have to believe its immune globulin franchise, led by ASCENIV, can keep gaining clinical traction while the new yield enhancement process and plasma network underpin improving economics. The short-seller dispute puts a spotlight on near term confidence in reported ASCENIV demand, but the comp
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman InvestigatingPR Newswire
- $ADMA Investor News: ADMA Biologics Faces Securities Fraud Investigation after Culper Research Revelation Leads to 29% Stock Drop – BFA Law Notifies Investors to ActGlobeNewswire
- ADMA Biologics (ADMA) Soars 11.6% as Firm Denies Short Seller Allegations [Yahoo! Finance]Yahoo! Finance
- ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman InvestigatingGlobeNewswire
- ADMA BIOLOGICS, INC. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities FraudBusiness Wire
ADMA
Earnings
- 11/5/25 - Miss
ADMA
Sec Filings
- 3/27/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- 3/17/26 - Form 4
- ADMA's page on the SEC website